GENETIC VECTORS INC
SB-2, EX-27, 2000-08-24
PHARMACEUTICAL PREPARATIONS
Previous: GENETIC VECTORS INC, SB-2, EX-23.2, 2000-08-24
Next: REMINGTON PRODUCTS CO LLC, 8-K, 2000-08-24



<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                          0001017157
<NAME>                         GENETIC VECTORS,INC.

<S>                             <C>
<PERIOD-TYPE>                   6-mos
<FISCAL-YEAR-END>                               Dec-31-2000
<PERIOD-START>                                   Jan-1-2000
<PERIOD-END>                                    Jun-30-2000
<CASH>                                              174,189
<SECURITIES>                                              0
<RECEIVABLES>                                        29,503
<ALLOWANCES>                                              0
<INVENTORY>                                          20,512
<CURRENT-ASSETS>                                    254,250
<PP&E>                                              575,552
<DEPRECIATION>                                    (320,679)
<TOTAL-ASSETS>                                      748,016
<CURRENT-LIABILITIES>                             2,898,430
<BONDS>                                                   0
                                     0
                                               0
<COMMON>                                              3,733
<OTHER-SE>                                      (2,150,414)
<TOTAL-LIABILITY-AND-EQUITY>                        748,016
<SALES>                                              85,245
<TOTAL-REVENUES>                                     85,245
<CGS>                                                23,325
<TOTAL-COSTS>                                     1,465,207
<OTHER-EXPENSES>                                  2,780,790
<LOSS-PROVISION>                                          0
<INTEREST-EXPENSE>                                        0
<INCOME-PRETAX>                                 (4,160,752)
<INCOME-TAX>                                              0
<INCOME-CONTINUING>                             (4,160,752)
<DISCONTINUED>                                            0
<EXTRAORDINARY>                                           0
<CHANGES>                                                 0
<NET-INCOME>                                    (4,160,752)
<EPS-BASIC>                                          (1.16)
<EPS-DILUTED>                                        (1.16)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission